about
BRAF Mutation in Hairy Cell LeukemiaBone Marrow Blood Vessels: Normal and Neoplastic NicheSignificance of oncogenes and tumor suppressor genes in AML prognosis.Safety and Efficacy of PDpoetin for Management of Anemia in Patients with end Stage Renal Disease on Maintenance Hemodialysis: Results from a Phase IV Clinical Trial.Combination of cyclophosphamide, etoposide, carboplatin and dexamethasone as a salvage regimen for refractory multiple myeloma patients: a comparison with a historical control group.Infection Pattern of Neutropenic Patients in Post-chemotherapy Phase of Acute Leukemia Treatment.Intermediate-Risk Chronic Stable Angina: Neutrophil-Lymphocyte Ratio and Fibrinogen Levels Improved Predicting Angiographically-Detected Coronary Artery Disease.New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia.The role of Pax5 in leukemia: diagnosis and prognosis significance.Targeting PI3K/AKT/mTOR network for treatment of leukemia.Regulatory effect of chemokines in bone marrow niche.Twist as a new prognostic marker in hematological malignancies.Central nervous system niche involvement in the leukemia.Wnt/β-catenin signaling in bone marrow niche.Hepatic metastatic niche: from normal to pre-metastatic and metastatic niche.Signaling and molecular basis of bone marrow niche angiogenesis in leukemia.Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells.The expression pattern of APC2 and APC7 in various cancer cell lines and AML patients.Factor VIII concentration is greater in female than male patients with HIV infection.
P50
Q27014016-28D60AC1-7E6B-4F18-B103-0B414F37F50BQ28067400-516D1288-22B8-4BDE-809B-23EBD3600E02Q30250315-65497754-B295-4176-8C9C-1B026167B0C7Q34325810-031D3CFE-B9AB-47F4-B5C0-EEFC76C08D83Q36331737-F5CD45ED-6107-4137-BA0E-43D02459FFAEQ37442571-39F5C4BE-B9A6-43F4-B784-82E404C1DE6FQ37598013-F760BBED-CE7F-40EB-BFB6-A7D238A0ED46Q38252432-2C1383FC-23A5-4EC9-B0FB-FB206C271A04Q38271843-C0CF7B37-21B2-4EBA-A34C-13397BEE48D0Q38364871-89496F5C-262A-4B7C-81AC-50274B361582Q38365227-34EC3FCB-D2D7-4B0C-A1C7-A184DBA00CAFQ38552664-4BDDF44A-2E8F-4EC8-B84B-54238BB0A924Q38560970-7CB9CD4F-9B06-4EFC-9ABA-5B7355D33149Q38609596-CEC10322-5CA2-4A27-94F5-788A3A35B30BQ38668174-4342F469-87CA-4004-9ADD-8336C15ABD16Q38689750-847F7031-6EB7-4801-8C3E-E45AC1311B39Q38736947-F6730B04-796D-4796-8DFA-5367122BB7ACQ38867117-D644DA62-B9BA-4D39-A9C6-39CC102974B2Q51527933-3C966A3E-BEE7-448A-A2F2-121662F74305
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ahmad Ahmadzadeh
@en
Ahmad Ahmadzadeh
@nl
type
label
Ahmad Ahmadzadeh
@en
Ahmad Ahmadzadeh
@nl
prefLabel
Ahmad Ahmadzadeh
@en
Ahmad Ahmadzadeh
@nl
P31
P496
0000-0002-2681-389X